Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 8-nitro-6-(o-chlorophenyl)-1,2-dihydro-2-(n-methylpiperazin-1-yl)methylene-1h,4h-imidazo (1,2-a)(1,4)benzodiazepin-1-one Methanesulfonate
2. Hr 158
3. Hr 458
4. Loprazolam
5. Ru 31158
6. Triazulenone
7. Triazulenone Mesylate
8. Triazulenone, (z)-isomer
1. Loprazolam Mesilate
2. Dormonoct
3. Loprazolam Methanesulfonate
4. Somnovit
5. Sonin
6. Havlane
7. 70111-54-5
8. Ru-31158
9. Vkf8383j65
10. Hr-158
11. Triazulenone Mesylate
12. Unii-vkf8383j65
13. Havlane (tn)
14. Hr 158
15. Schembl352745
16. 61197-93-1
17. Loprazolam Mesilate [mart.]
18. Loprazolam Mesilate [who-dd]
19. Loprazolam Methanesulfonate [mi]
20. D08145
21. Q27291872
22. (2z)-6-(2-chlorophenyl)-2-[(4-methylpiperazin-1-yl)methylidene]-8-nitro-4h-imidazo[1,2-a][1,4]benzodiazepin-1-one;methanesulfonic Acid
23. (z)-6-(2-chlorophenyl)-2-((4-methylpiperazin-1-yl)methylene)-8-nitro-2,4-dihydro-1h-benzo[f]imidazo[1,2-a][1,4]diazepin-1-one Methanesulfonate
24. 1h-imidazo(1,2-a)(1,4)benzodiazepin-1-one, 6-(2-chlorophenyl)-2,4-dihydro-2-((4-methyl-1-piperazinyl)methylene)-8-nitro-, (2z)-, Methanesulfonate (1:1)
25. 1h-imidazo(1,2-a)(1,4)benzodiazepin-1-one, 6-(2-chlorophenyl)-2,4-dihydro-2-((4-methyl-1-piperazinyl)methylene)-8-nitro-, Monomethanesulfonate
| Molecular Weight | 561.0 g/mol |
|---|---|
| Molecular Formula | C24H25ClN6O6S |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 2 |
| Exact Mass | 560.1244814 g/mol |
| Monoisotopic Mass | 560.1244814 g/mol |
| Topological Polar Surface Area | 160 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 984 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
ABOUT THIS PAGE
A Loprazolam Mesilate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Loprazolam Mesilate, including repackagers and relabelers. The FDA regulates Loprazolam Mesilate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Loprazolam Mesilate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Loprazolam Mesilate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Loprazolam Mesilate supplier is an individual or a company that provides Loprazolam Mesilate active pharmaceutical ingredient (API) or Loprazolam Mesilate finished formulations upon request. The Loprazolam Mesilate suppliers may include Loprazolam Mesilate API manufacturers, exporters, distributors and traders.
click here to find a list of Loprazolam Mesilate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Loprazolam Mesilate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Loprazolam Mesilate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Loprazolam Mesilate GMP manufacturer or Loprazolam Mesilate GMP API supplier for your needs.
A Loprazolam Mesilate CoA (Certificate of Analysis) is a formal document that attests to Loprazolam Mesilate's compliance with Loprazolam Mesilate specifications and serves as a tool for batch-level quality control.
Loprazolam Mesilate CoA mostly includes findings from lab analyses of a specific batch. For each Loprazolam Mesilate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Loprazolam Mesilate may be tested according to a variety of international standards, such as European Pharmacopoeia (Loprazolam Mesilate EP), Loprazolam Mesilate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Loprazolam Mesilate USP).
LOOKING FOR A SUPPLIER?
